Fairfield, Bush & Co. Cyto Dyn Inc. Put Options Transaction History
Fairfield, Bush & Co.
- $168 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CYDY
# of Institutions
9Shares Held
406KCall Options Held
0Put Options Held
0-
Eagle Bay Advisors LLC New York, NY162KShares$17,8320.01% of portfolio
-
Mai Capital Management47.5KShares$5,2230.0% of portfolio
-
Diversified Trust CO45.8KShares$5,0360.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY45KShares$4,9500.0% of portfolio
-
Rfp Financial Group LLC Atlanta, GA41.5KShares$4,5590.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $89.4M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...